FEBRUARY 2015
Hematology
Pipeline Update
Drug Updates from the 2014 ASH Annual Meeting
2… Bleeding Disorders
Fusion Proteins,
ACE-536, and more
5… Lymphoma
Ibrutinib, PD-1
Inhibitors, and more
8… Leukemia
Idelalisib, AG-221,
and more
15… Myeloma
Anti-CD38 Antibodies,
Carfilzomib, and more
A Special Edition of
Your source for worldwide
news and perspectives
on hematology/oncology
www.ASHClinicalNews.org